Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
20
×
Tags
fda
20
×
life sciences
national blog main
biotech
clinical trials
boston blog main
boston top stories
national top stories
new york blog main
san francisco blog main
boston
deals
new york top stories
eli lilly
san diego blog main
san diego top stories
san francisco top stories
amgen
cancer
detroit blog main
detroit top stories
europe blog main
indiana blog main
indiana top stories
investing
national
novartis
sanofi
startups
alnylam pharmaceuticals
boulder/denver blog main
boulder/denver top stories
drugs
gilead sciences
ipo
melinta therapeutics
new york
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
What
medicines
20
×
drug
fda
new
ipo
therapeutics
approved
announced
approval
class
company
covid
deal
developing
disease
migraine
nod
pharmaceuticals
research
wins
bio
brings
cancer
candidate
cholesterol
companies
developed
helped
including
infections
late
lead
monday
muscle
pain
pharma
pill
plans
ready
regulatory
Language
unset
unknown
Current search:
fda
×
photo
×
medicines
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@slashgear.com
3 years ago
Popular children’s medicines recalled, but not for the reason you think
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@slashgear.com
4 years ago
Fake coronavirus cures targeted by feds as infections rise
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines